Gary Payton
A high-THC hybrid from Cookies and Powerzzzup Genetics, named after the NBA Hall of Famer and known for its loud, gassy aroma.
Gary Payton is a genuinely popular Cookies-family cultivar with a strong loud-gas profile, but most of what you read about it is marketing. There's no clinical research on this strain specifically. THC numbers vary widely between grows and labs, the 'balanced hybrid' label is meaningless biologically, and effect descriptions ('focused euphoria,' 'creative energy') are subjective consumer reports, not pharmacology. It's a well-bred plant with a recognizable terpene profile. That's the honest version.
Overview
Gary Payton is a hybrid cannabis cultivar released through Cookies, the Bay Area brand co-founded by Berner, in collaboration with Powerzzzup Genetics. It is named after the NBA Hall of Fame point guard Gary Payton, who licensed his name to the cultivar — an unusual celebrity arrangement that itself attracted press coverage [1][2].
The strain is part of the broader Cookies catalog that helped popularize the loud, gas-and-cookie aromatic style now dominant in U.S. dispensary menus. It's typically sold as flower in legal markets in California, Arizona, Massachusetts, and elsewhere Cookies operates, and as seeds/clones in gray-market channels.
Chemistry
Cannabinoids. Lab results published by licensed retailers commonly place Gary Payton flower in the 20–25% total THC range, with negligible CBD (<1%). Individual batches have been reported both higher and lower. There is no peer-reviewed chemotype analysis of this specific cultivar; figures come from state-required commercial COAs, which vary in methodology Weak / limited.
Terpenes. Commercial COAs and retailer listings most often report caryophyllene and limonene as the dominant terpenes, with humulene, linalool, and myrcene as common secondary notes. This is consistent with the pungent, fuel-and-citrus aroma described by consumers Weak / limited.
Claims that specific terpene percentages (e.g. 'myrcene above 0.5% makes it an indica') predict effects are folklore, not established pharmacology — the entourage effect is plausible but not well demonstrated for individual terpenes at inhaled doses [3] Disputed.
Reported effects
Consumers commonly describe Gary Payton as energetic, talkative, and cerebral, with a heavy body component at higher doses. Dispensary copy frequently calls it 'balanced' or 'uplifting.'
Important caveats:
- There are no clinical trials of Gary Payton specifically, and effectively none of any named cultivar. Strain-specific effect claims rest on user surveys and marketing, not pharmacology No data.
- Reviews of the cannabis literature have repeatedly found that 'indica vs. sativa' labels, and even strain names, do not reliably predict chemistry or subjective effects across batches and producers [4][5] Strong evidence.
- Adverse effects reported with high-THC flower in general — anxiety, tachycardia, impaired short-term memory and coordination — apply here. THC at 20%+ is potent regardless of the name on the jar [6] Strong evidence.
Treat effect descriptions as 'what some users say about some batches,' not as reliable predictions for you.
Lineage
Gary Payton is widely reported as a cross of The Y (a.k.a. Y Griega, sometimes written as Y) and Snowman (a Girl Scout Cookies phenotype) [1] Weak / limited.
This lineage is the version promoted by Cookies and Powerzzzup and is the most commonly cited in industry coverage. However:
- Cannabis pedigrees in general are difficult to verify because plant material is rarely genotyped and breeder records are private.
- Independent genetic work (e.g. Phylos and academic groups) has repeatedly shown that strain names do not reliably correspond to genetic clusters [7] Strong evidence.
- 'Gary Payton' sold by non-Cookies vendors may be unrelated phenotypes carrying the name.
So: the official story is The Y × Snowman. Treat that as the breeder's claim, not a verified fact.
Cultivation basics
Authentic Gary Payton genetics are distributed through Cookies and a limited number of partners; most 'Gary Payton seeds' on the open market are S1 reproductions or unrelated crosses using the name.
Grower reports (not controlled trials) suggest:
- Flowering time: roughly 8–9 weeks indoors.
- Structure: medium height, moderate stretch, responds well to topping and SCROG.
- Yield: moderate; not a commercial yield leader, valued more for aroma and bag appeal.
- Environment: prefers stable temps (low- to mid-20s °C) and moderate humidity; dense colas can be susceptible to bud rot if humidity is high late in flower.
- Difficulty: intermediate. Not especially finicky, but nutrient-sensitive and rewards careful environmental control.
These are aggregated impressions from grower forums and seed-vendor descriptions Anecdote.
Marketing vs. reality
What's real:
- Gary Payton is a legitimately bred Cookies-family cultivar with a distinctive loud-gas aroma and a documented celebrity licensing deal [1][2].
- It is consistently potent in THC by commercial standards.
What's marketing:
- 'Balanced hybrid' / 'uplifting sativa-leaning' language — these labels don't map onto verified chemistry or pharmacology [4] Strong evidence.
- Specific effect promises ('focus,' 'creativity,' 'social energy') — not clinically demonstrated for this or any named strain No data.
- 'Authentic Gary Payton seeds' sold outside Cookies channels — usually S1s or namesake crosses, not the original cut.
- Terpene-percentage rules of thumb for predicting effects — folklore, not pharmacology [3] Disputed.
If you like the smell and you tolerate high-THC flower, it's a reasonable choice. The hype around the name is doing a lot of the work.
Sources
- Reported Schiller, G. (2021). 'Gary Payton on His Cannabis Strain and Partnership With Cookies.' Rolling Stone.
- Reported Forbes Staff (2021). 'NBA Hall Of Famer Gary Payton Partners With Cannabis Brand Cookies.' Forbes.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Peer-reviewed Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 374(9698), 1383–1391.
- Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015). The genetic structure of marijuana and hemp. PLOS ONE, 10(8), e0133292.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Girl Scout Cookies — The Bay Area hybrid that defined the 2010s cannabis market, with a famously messy lineage...